Literature DB >> 16149899

Gendicine: the first commercial gene therapy product.

James M Wilson.   

Abstract

Mesh：

Year:  2005        PMID： 16149899     DOI： 10.1089/hum.2005.16.1014

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  25 in total

1.  One-pot Synthesis of Functional Poly(amino ester sulfide)s and Utility in Delivering pDNA and siRNA.

Authors:  Yunfeng Yan; Lian Xue; Jason B Miller; Kejin Zhou; Petra Kos; Sussana Elkassih; Li Liu; Atsushi Nagai; Hu Xiong; Daniel J Siegwart
Journal:  Polymer (Guildf)       Date:  2015-08-18       Impact factor: 4.430

Review 2.  Functional lipids and lipoplexes for improved gene delivery.

Authors:  Xiao-Xiang Zhang; Thomas J McIntosh; Mark W Grinstaff
Journal:  Biochimie       Date:  2011-05-20       Impact factor: 4.079

3.  CRISPR as a driving force: the Model T of biotechnology.

Authors:  Carlos Mariscal; Angel Petropanagos
Journal:  Monash Bioeth Rev       Date:  2016-06

4.  The Effect of CXCR4 Overexpression on Mesenchymal Stem Cell Transplantation in Ischemic Stroke.

Authors:  Oh Young Bang; Kyung Sil Jin; Mi Na Hwang; Ho Young Kang; Byoung Joon Kim; Sang Jin Lee; Sangmee Kang; Yu Kyeong Hwang; Jong Seong Ahn; Ki Woong Sung
Journal:  Cell Med       Date:  2012-05-15

Review 5.  A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiforme.

Authors:  Thomas Wirth
Journal:  World J Exp Med       Date:  2011-12-20

Review 6.  Current status of gene therapy for rheumatoid arthritis.

Authors:  Daniel F Gaddy; Paul D Robbins
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 7.  Gene replacement therapy for genetic hepatocellular jaundice.

Authors:  Remco van Dijk; Ulrich Beuers; Piter J Bosma
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

8.  Dystrophin Gene Replacement and Gene Repair Therapy for Duchenne Muscular Dystrophy in 2016: An Interview.

Authors:  Dongsheng Duan
Journal:  Hum Gene Ther Clin Dev       Date:  2016-03       Impact factor: 5.032

9.  Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection.

Authors:  J C M van der Loo; W P Swaney; E Grassman; A Terwilliger; T Higashimoto; A Schambach; C Baum; A J Thrasher; D A Williams; D L Nordling; L Reeves; P Malik
Journal:  Gene Ther       Date:  2011-07-14       Impact factor: 5.250

Review 10.  Gene therapy of the rheumatic diseases: 1998 to 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.